Literature DB >> 29908485

Myeloid Kdm6b deficiency results in advanced atherosclerosis.

Annette E Neele1, Marion J J Gijbels2, Saskia van der Velden3, Marten A Hoeksema3, Marieke C S Boshuizen3, Koen H M Prange3, Hung-Jen Chen3, Jan Van den Bossche3, Cindy P P A van Roomen3, Annelie Shami3, Johannes H M Levels4, Jeffrey Kroon4, Tina Lucas5, Stefanie Dimmeler5, Esther Lutgens6, Menno P J de Winther7.   

Abstract

BACKGROUND AND AIMS: Atherosclerosis is a lipid-driven chronic inflammatory disorder of the arteries, and monocytes and macrophages play a central role in this process. Within the atherosclerotic lesion, macrophages can scavenge modified lipids and become the so-called foam cells. We previously reported that the epigenetic enzyme Kdm6b (also known as Jmjd3) controls the pro-fibrotic transcriptional profile of peritoneal foam cells. Given the importance of these cells in atherosclerosis, we now studied the effect of myeloid Kdm6b on disease progression.
METHODS: Bone marrow of myeloid Kdm6b deficient (Kdm6bdel) mice or wild type littermates (Kdm6bwt) was transplanted to lethally irradiated Ldlr-/- mice fed a high fat diet for 9 weeks to induce atherosclerosis.
RESULTS: Lesion size was similar in Kdm6bwt and Kdm6bdel transplanted mice. However, lesions of Kdm6bdel mice contained more collagen and were more necrotic. Pathway analysis on peritoneal foam cells showed that the pathway involved in leukocyte chemotaxis was most significantly upregulated. Although macrophage and neutrophil content was similar after 9 weeks of high fat diet feeding, the relative increase in collagen content and necrosis revealed that atherosclerotic lesions in Kdm6bdel mice progress faster.
CONCLUSION: Myeloid Kdm6b deficiency results in more advanced atherosclerosis.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Epigenetic; H3K27; Histone modification; Jmjd3; Kdm6b; Macrophage

Mesh:

Substances:

Year:  2018        PMID: 29908485     DOI: 10.1016/j.atherosclerosis.2018.05.052

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

1.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

Review 2.  Transcriptional and epigenetic regulation of macrophages in atherosclerosis.

Authors:  Tatyana Kuznetsova; Koen H M Prange; Christopher K Glass; Menno P J de Winther
Journal:  Nat Rev Cardiol       Date:  2019-10-02       Impact factor: 32.419

3.  Identifying the key microRNAs implicated in atrial fibrillation.

Authors:  Yuejuan Cao; Li Cui
Journal:  Anatol J Cardiol       Date:  2021-06       Impact factor: 1.596

4.  Targeting epigenetic modifiers to reprogramme macrophages in non-resolving inflammation-driven atherosclerosis.

Authors:  Fengyan Jin; Jian Li; Jianfeng Guo; Thorsten R Doeppner; Dirk M Hermann; Gang Yao; Yun Dai
Journal:  Eur Heart J Open       Date:  2021-08-17

5.  Inhibition of macrophage histone demethylase JMJD3 protects against abdominal aortic aneurysms.

Authors:  Frank M Davis; Lam C Tsoi; William J Melvin; Aaron denDekker; Rachael Wasikowski; Amrita D Joshi; Sonya Wolf; Andrea T Obi; Allison C Billi; Xianying Xing; Christopher Audu; Bethany B Moore; Steven L Kunkel; Alan Daugherty; Hong S Lu; Johann E Gudjonsson; Katherine A Gallagher
Journal:  J Exp Med       Date:  2021-06-07       Impact factor: 14.307

6.  Myeloid Ezh2 Deficiency Limits Atherosclerosis Development.

Authors:  Annette E Neele; Hung-Jen Chen; Marion J J Gijbels; Saskia van der Velden; Marten A Hoeksema; Marieke C S Boshuizen; Jan Van den Bossche; Anton T Tool; Hanke L Matlung; Timo K van den Berg; Esther Lutgens; Menno P J de Winther
Journal:  Front Immunol       Date:  2021-01-26       Impact factor: 7.561

7.  Inhibition of Histone H3 Lysine-27 Demethylase Activity Relieves Rheumatoid Arthritis Symptoms via Repression of IL6 Transcription in Macrophages.

Authors:  Zhan Zhao; Yazhuo Zhang; Danling Gao; Yidan Zhang; Wenwei Han; Ximing Xu; Qiaoling Song; Chenyang Zhao; Jinbo Yang
Journal:  Front Immunol       Date:  2022-03-15       Impact factor: 7.561

Review 8.  Diverse Epigenetic Regulations of Macrophages in Atherosclerosis.

Authors:  Hongmei Yang; Yue Sun; Qingchao Li; Fengyan Jin; Yun Dai
Journal:  Front Cardiovasc Med       Date:  2022-03-29

9.  Myeloid-associated lipin-1 transcriptional co-regulatory activity is atheroprotective.

Authors:  Cassidy M R Blackburn; Robert M Schilke; Aimee E Vozenilek; Sunitha Chandran; Temitayo T Bamgbose; Brian N Finck; Matthew D Woolard
Journal:  Atherosclerosis       Date:  2021-07-01       Impact factor: 6.847

Review 10.  Targeting epigenetics as atherosclerosis treatment: an updated view.

Authors:  Annette E Neele; Lisa Willemsen; Hung-Jen Chen; Kim E Dzobo; Menno P J de Winther
Journal:  Curr Opin Lipidol       Date:  2020-12       Impact factor: 4.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.